Gary Gibbons, M.D., is retiring as…
Gary Gibbons, M.D., is retiring as National Heart, Lung and [...]
Gary Gibbons, M.D., is retiring as National Heart, Lung and [...]
A study of more than 5,000 pages of agency documents [...]
Already on track to achieve blockbuster status in its third [...]
A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 [...]
With $10 billion pledged to beef up its U.S. operations [...]
Teva has penned a second pact with Royalty Pharma, this [...]
Eikon Therapeutics is planning to become the second biotech to [...]
His discovery of the protein fragment GLP-1 was crucial in [...]
Sam Rodriques, the C.E.O. and co-founder of FutureHouse, discusses the [...]
The new year has ushered in a flow of biotech-specific [...]